Glucose Effectiveness in Obese Children: Relation to Degree of Obesity and Dysglycemia

Overview

Journal Diabetes Care

Specialty Endocrinology

Date 2015 Jan 31

PMID 25633663

Citations 17

Authors

Ram Weiss

Sheela N Magge

Nicola Santoro

Cosimo Giannini

Raymond Boston

Tara Holder

Melissa Shaw

Elvira Duran

Karen J Hershkop

Sonia Caprio

Affiliations

Soon will be listed here.

Abstract

Objective: Impaired glucose effectiveness (GE) plays a role in the deterioration of glucose metabolism. Our aim was to validate a surrogate of GE derived from an oral glucose tolerance test (OGTT) and to assess the impact of degrees of obesity and of glucose tolerance on it.

Research Design And Methods: The OGTT-derived surrogate of GE (oGE) was validated in obese adolescents who underwent an OGTT and an intravenous glucose tolerance test (IVGTT). We then evaluated anthropometric determinants of the oGE and its impact on the dynamics of glucose tolerance in a cohort of children with varying degrees of obesity.

Results: The correlation of oGE and IVGTT-derived GE in 98 obese adolescents was r = 0.35 (P < 0.001) as a whole and r = 0.51 (P < 0.001) in subjects with normal glucose tolerance. In a cohort of 1,418 children, the adjusted GE was associated with increasing obesity (P < 0.001 for each category of obesity). Quartiles of oGE and the oral disposition index were associated with 2-h glucose levels (P < 0.001 for both). Among 421 nondiabetic obese subjects (276 subjects with normal glucose tolerance/145 subjects with impaired glucose tolerance who repeated their OGTT after a mean time of 28 ± 16 months), oGE changes were tightly associated with weight (r = 0.83, P < 0.001) and waist circumference changes (r = 0.67, P < 0.001). Baseline oGE and changes in oGE over time emerged as significant predictors of the change in 2-h glucose levels (standardized B = -0.76 and B = -0.98 respectively, P < 0.001 for both).

Conclusions: The oGE is associated with the degree of and changes in weight and waist circumference and is an independent predictor of glucose tolerance dynamics.

Citing Articles

Prevalence and Predictive Clinical Characteristics of Metabolically Healthy Obesity in Obese Children and Adolescents.

Dundar I, Akinci A Cureus. 2023; 15(3):e35935.

PMID: 37038589 PMC: 10082589. DOI: 10.7759/cureus.35935.

Autoimmune reaction against pancreatic beta cells in children and adolescents with simple obesity.

Chylinska-Fratczak A, Pietrzak I, Michalak A, Wyka K, Szadkowska A Front Endocrinol (Lausanne). 2023; 13:1061671.

PMID: 36589801 PMC: 9794760. DOI: 10.3389/fendo.2022.1061671.

Association of total and pancreatic serum amylase enzymatic activity with insulin resistance and the glucose and insulin responses to oral starch test in Mexican children.

Locia-Morales D, Vazquez-Moreno M, Gonzalez-Dzib R, Dominguez-Hernandez C, Perez-Herrera A, Robles-Ramirez R Pediatr Obes. 2022; 17(12):e12965.

PMID: 36350201 PMC: 9787783. DOI: 10.1111/ijpo.12965.

Effects of interrupting daily sedentary behavior on children's glucose metabolism: A 6-day randomized controlled trial.

Broadney M, Belcher B, Ghane N, Sheni R, Jayson M, Trenschel R Pediatr Diabetes. 2022; 23(8):1567-1578.

PMID: 36205036 PMC: 9772039. DOI: 10.1111/pedi.13430.

Relation of glomerular filtration to insulin resistance and related risk factors in obese children.

Magen D, Halloun R, Galderisi A, Caprio S, Weiss R Int J Obes (Lond). 2021; 46(2):374-380.

PMID: 34725443 DOI: 10.1038/s41366-021-01001-2.

References

Schwartz M, Seeley R, Tschop M, Woods S, Morton G, Myers M . Cooperation between brain and islet in glucose homeostasis and diabetes. Nature. 2013; 503(7474):59-66. PMC: 3983910. DOI: 10.1038/nature12709. View

Ward G, Walters J, Barton J, Alford F, Boston R . Physiologic modeling of the intravenous glucose tolerance test in type 2 diabetes: a new approach to the insulin compartment. Metabolism. 2001; 50(5):512-9. DOI: 10.1053/meta.2001.21029. View

Egede M, Henriksen J, Durck T, Levin K, Rantzau C, Ward G . Glucose effectiveness in nondiabetic relatives: dysglycemia and β-cell function at 10 years. J Clin Endocrinol Metab. 2014; 99(4):1420-4. DOI: 10.1210/jc.2013-3273. View

Ogden C, Kuczmarski R, Flegal K, Mei Z, Guo S, Wei R . Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002; 109(1):45-60. DOI: 10.1542/peds.109.1.45. View

Vahl T, Paty B, Fuller B, Prigeon R, DAlessio D . Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1- (9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans. J Clin Endocrinol Metab. 2003; 88(4):1772-9. DOI: 10.1210/jc.2002-021479. View

Weiss R, Dufour S, Taksali S, Tamborlane W, Petersen K, Bonadonna R . Prediabetes in obese youth: a syndrome of impaired glucose tolerance, severe insulin resistance, and altered myocellular and abdominal fat partitioning. Lancet. 2003; 362(9388):951-7. PMC: 2995523. DOI: 10.1016/S0140-6736(03)14364-4. View

Hawkins M, Tonelli J, Kishore P, Stein D, Ragucci E, Gitig A . Contribution of elevated free fatty acid levels to the lack of glucose effectiveness in type 2 diabetes. Diabetes. 2003; 52(11):2748-58. DOI: 10.2337/diabetes.52.11.2748. View

Yeckel C, Weiss R, Dziura J, Taksali S, Dufour S, Burgert T . Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab. 2004; 89(3):1096-101. DOI: 10.1210/jc.2003-031503. View

Weiss R, Dziura J, Burgert T, Tamborlane W, Taksali S, Yeckel C . Obesity and the metabolic syndrome in children and adolescents. N Engl J Med. 2004; 350(23):2362-74. DOI: 10.1056/NEJMoa031049. View

10.

Bergman R, Finegood D, Ader M . Assessment of insulin sensitivity in vivo. Endocr Rev. 1985; 6(1):45-86. DOI: 10.1210/edrv-6-1-45. View

11.

Pacini G, Bergman R . MINMOD: a computer program to calculate insulin sensitivity and pancreatic responsivity from the frequently sampled intravenous glucose tolerance test. Comput Methods Programs Biomed. 1986; 23(2):113-22. DOI: 10.1016/0169-2607(86)90106-9. View

12.

DAlessio D, Kahn S, Leusner C, ENSINCK J . Glucagon-like peptide 1 enhances glucose tolerance both by stimulation of insulin release and by increasing insulin-independent glucose disposal. J Clin Invest. 1994; 93(5):2263-6. PMC: 294382. DOI: 10.1172/JCI117225. View

13.

Taniguchi A, Nakai Y, Fukushima M, Imura H, Kawamura H, Nagata I . Insulin sensitivity, insulin secretion, and glucose effectiveness in subjects with impaired glucose tolerance: a minimal model analysis. Metabolism. 1994; 43(6):714-8. DOI: 10.1016/0026-0495(94)90119-8. View

14.

Phillips D, Clark P, Hales C, Osmond C . Understanding oral glucose tolerance: comparison of glucose or insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994; 11(3):286-92. DOI: 10.1111/j.1464-5491.1994.tb00273.x. View

15.

Prigeon R, Roder M, Porte Jr D, Kahn S . The effect of insulin dose on the measurement of insulin sensitivity by the minimal model technique. Evidence for saturable insulin transport in humans. J Clin Invest. 1996; 97(2):501-7. PMC: 507043. DOI: 10.1172/JCI118441. View

16.

Hoffman R, Armstrong P . Glucose effectiveness, peripheral and hepatic insulin sensitivity, in obese and lean prepubertal children. Int J Obes Relat Metab Disord. 1996; 20(6):521-5. View

17.

Best J, Kahn S, Ader M, Watanabe R, Ni T, Bergman R . Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care. 1996; 19(9):1018-30. DOI: 10.2337/diacare.19.9.1018. View

18.

Basu A, Caumo A, Bettini F, Gelisio A, AlZaid A, Cobelli C . Impaired basal glucose effectiveness in NIDDM: contribution of defects in glucose disappearance and production, measured using an optimized minimal model independent protocol. Diabetes. 1997; 46(3):421-32. DOI: 10.2337/diab.46.3.421. View

19.

Doi K, Taniguchi A, Nakai Y, Kawamura H, Higaki Y, Yokoi H . Decreased glucose effectiveness but not insulin resistance in glucose-tolerant offspring of Japanese non-insulin-dependent diabetic patients: a minimal-model analysis. Metabolism. 1997; 46(8):880-3. DOI: 10.1016/s0026-0495(97)90073-1. View

20.

Mari A . Assessment of insulin sensitivity and secretion with the labelled intravenous glucose tolerance test: improved modelling analysis. Diabetologia. 1998; 41(9):1029-39. DOI: 10.1007/s001250051027. View